openFDA 执法报告 D-0080-2027:Huons 羧甲基纤维素钠 0.5% 无菌润滑滴眼液因杂质/降解规格不合格被列为 II 类召回
FDA drug enforcement D-0080-2027: Huons Co., Ltd. — Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers
openFDA 执法报告 D-0080-2027 收录 Huons 羧甲基纤维素钠 0.5% 无菌润滑滴眼液的 II 类召回,原因为杂质/降解规格不合格并检出聚乙烯相关低聚物。
记录列出该滴眼液 II 类召回的原因、批次范围、数量及美国分销信息,可供核对本次召回记录。
FDA 药品召回执法报告 — D-0080-2027
报告发布日期:2026-11-04。这是执法报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。无召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于追踪召回生命周期。以下其他日期保留其各自名称所对应的含义。
完整官方产品记录(含 openFDA 统一标识符):
{
"address_1": "137 Bio Valley-Ro",
"address_2": "",
"center_classification_date": "20261026",
"city": "Jecheon",
"classification": "Class II",
"code_info": "Lot: 2EQH501, Exp. 3/12/2027; 2EQH502, 2EQH503, 2EQH504, 2EQH505, Exp. 3/16/2027; 2EQH506, 2EQH507, Exp. 5/22/2027; 2EQH508, Exp. 5/26/2027; 2EQH509, Exp. 5/27/2027; 2EQH510, 2EQH511, 2EQH512, 2EQH513, Exp. 10/13/2028.",
"country": "Korea (the Republic of)",
"distribution_pattern": "Nationwide within U.S.",
"event_id": "100011",
"initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
"more_code_info": "",
"openfda": {},
"postal_code": "N/A",
"product_description": "Carboxymethylcellulose Sodium, 0.5% Lubricant Eye Drops, Sterile, 30 Single-Use Containers, 0.02 FL OZ (0.5 mL) each, Manufactured by: Huons Co., Ltd, Jecheon-si, Chungcheongbuk-do, 27159, South Korea; Marketed by: GSMS Incorporated, Camarillo, CA 93012, USA. NDC 51407-945-30 Pouch Label: Carboxymethylcellulose Sodium, Lubricant Eye Drops, 0.5 mL, Single-Use, gsms.",
"product_quantity": "6,633,570 tubes",
"product_type": "Drugs",
"reason_for_recall": "Failed Impurities/Degradation Specification; detection of polyethylene (PE)-related oligomers",
"recall_initiation_date": "20261002",
"recall_number": "D-0080-2027",
"recalling_firm": "Huons Co., Ltd.",
"report_date": "20261104",
"state": "",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov